Italy, Germany, France and the Netherlands have signed a contract with Astrazeneca to supply European citizens with a vaccine against the coronavirus, Italy's health minister said.
The contract is for 400 million doses of the vaccine, which was developed with the University of Oxford and whose experimentation phase is already advanced and expected to end in autumn, Roberto Speranza said in a Facebook post.
He added that a first batch of doses would be made available by the end of this year.





























